关注
Atsushi Nakajima
Atsushi Nakajima
未知所在单位机构
在 umin.ac.jp 的电子邮件经过验证
标题
引用次数
引用次数
年份
Modeling nafld disease burden in china, france, germany, italy, japan, spain, united kingdom, and united states for the period 2016–2030
C Estes, QM Anstee, MT Arias-Loste, H Bantel, S Bellentani, J Caballeria, ...
Journal of hepatology 69 (4), 896-904, 2018
17222018
Magnetic resonance imaging more accurately classifies steatosis and fibrosis in patients with nonalcoholic fatty liver disease than transient elastography
K Imajo, T Kessoku, Y Honda, W Tomeno, Y Ogawa, H Mawatari, K Fujita, ...
Gastroenterology 150 (3), 626-637. e7, 2016
8502016
Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
Y Sumida, A Nakajima, Y Itoh
World journal of gastroenterology: WJG 20 (2), 475, 2014
7062014
Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD)
M Yoneda, H Mawatari, K Fujita, H Endo, H Iida, Y Nozaki, K Yonemitsu, ...
Digestive and Liver Disease 40 (5), 371-378, 2008
5342008
FOXP3+ Regulatory T Cells Affect the Development and Progression of Hepatocarcinogenesis
N Kobayashi, N Hiraoka, W Yamagami, H Ojima, Y Kanai, T Kosuge, ...
Clinical Cancer Research 13 (3), 902-911, 2007
5192007
Nonalcoholic fatty liver disease: US-based acoustic radiation force impulse elastography
M Yoneda, K Suzuki, S Kato, K Fujita, Y Nozaki, K Hosono, S Saito, ...
Radiology 256 (2), 640-647, 2010
4772010
Metformin suppresses colorectal aberrant crypt foci in a short-term clinical trial
K Hosono, H Endo, H Takahashi, M Sugiyama, E Sakai, T Uchiyama, ...
Cancer prevention research 3 (9), 1077-1083, 2010
4062010
High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH
M Yoneda, H Mawatari, K Fujita, H Iida, K Yonemitsu, S Kato, ...
Journal of gastroenterology 42, 573-582, 2007
3872007
Hyperresponsivity to low-dose endotoxin during progression to nonalcoholic steatohepatitis is regulated by leptin-mediated signaling
K Imajo, K Fujita, M Yoneda, Y Nozaki, Y Ogawa, Y Shinohara, S Kato, ...
Cell metabolism 16 (1), 44-54, 2012
3792012
Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis
FE Mózes, JA Lee, EA Selvaraj, ANA Jayaswal, M Trauner, J Boursier, ...
Gut 71 (5), 1006-1019, 2022
3542022
Magnetic resonance vs transient elastography analysis of patients with nonalcoholic fatty liver disease: a systematic review and pooled analysis of individual participants
C Hsu, C Caussy, K Imajo, J Chen, S Singh, K Kaulback, MD Le, J Hooker, ...
Clinical Gastroenterology and Hepatology 17 (4), 630-637. e8, 2019
3492019
Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
S Watanabe, E Hashimoto, K Ikejima, H Uto, M Ono, Y Sumida, M Seike, ...
Journal of gastroenterology 50 (4), 364-377, 2015
3492015
Transient elastography in patients with non-alcoholic fatty liver disease (NAFLD)
M Yoneda, K Fujita, M Inamori, A Nakajima, M Tamano, H Hiraishi
Gut 56 (9), 1330-1331, 2007
3382007
Metformin for chemoprevention of metachronous colorectal adenoma or polyps in post-polypectomy patients without diabetes: a multicentre double-blind, placebo-controlled …
T Higurashi, K Hosono, H Takahashi, Y Komiya, S Umezawa, E Sakai, ...
The Lancet Oncology 17 (4), 475-483, 2016
3272016
Variations in the FTO gene are associated with severe obesity in the Japanese
K Hotta, Y Nakata, T Matsuo, S Kamohara, K Kotani, R Komatsu, N Itoh, ...
Journal of human genetics 53 (6), 546-553, 2008
3272008
Endogenous PPARγ mediates anti-inflammatory activity in murine ischemia-reperfusion injury
A Nakajima, K Wada, H Miki, N Kubota, N Nakajima, Y Terauchi, ...
Gastroenterology 120 (2), 460-469, 2001
3222001
Involvement of a periodontal pathogen, Porphyromonas gingivalis on the pathogenesis of non-alcoholic fatty liver disease
M Yoneda, S Naka, K Nakano, K Wada, H Endo, H Mawatari, K Imajo, ...
BMC gastroenterology 12, 1-10, 2012
3062012
Dysfunctional very‐low‐density lipoprotein synthesis and release is a key factor in nonalcoholic steatohepatitis pathogenesis
K Fujita, Y Nozaki, K Wada, M Yoneda, Y Fujimoto, M Fujitake, H Endo, ...
Hepatology 50 (3), 772-780, 2009
2932009
Peroxisome proliferator-activated receptor γ ligands suppress colon carcinogenesis induced by azoxymethane in mice
E Osawa, A Nakajima, K Wada, S Ishimine, N Fujisawa, T Kawamori, ...
Gastroenterology 124 (2), 361-367, 2003
2852003
Patients with colorectal cancer have identical strains of Fusobacterium nucleatum in their colorectal cancer and oral cavity
Y Komiya, Y Shimomura, T Higurashi, Y Sugi, J Arimoto, S Umezawa, ...
Gut 68 (7), 1335-1337, 2019
2502019
系统目前无法执行此操作,请稍后再试。
文章 1–20